[
    [
        {
            "time": "2023-11-15",
            "original_text": "【港股通】药明康德(02359)股东Summer Bloom累计减持约1498.92万股 减持股份",
            "features": {
                "keywords": [
                    "药明康德",
                    "Summer Bloom",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【港股通】药明康德(02359)股东Summer Bloom累计减持约1498.92万股 减持股份",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-11-15",
            "original_text": "药明康德(02359)股东Summer Bloom Investment (I) Pte. Ltd.累计减持约1498.92万股 减持股份",
            "features": {
                "keywords": [
                    "药明康德",
                    "Summer Bloom",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德(02359)股东Summer Bloom Investment (I) Pte. Ltd.累计减持约1498.92万股 减持股份",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-11-15",
            "original_text": "药明康德：Summer Bloom Investment (I) Pte. Ltd.根据本次减持计划已合计减持约1499万股本公司股份，计划减持数量未全部实施完毕 拟减持股份",
            "features": {
                "keywords": [
                    "药明康德",
                    "Summer Bloom",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德：Summer Bloom Investment (I) Pte. Ltd.根据本次减持计划已合计减持约1499万股本公司股份，计划减持数量未全部实施完毕 拟减持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-11-15",
            "original_text": "药明康德(603259.SH)：Summer Bloom完成减持1498.918万股 减持股份",
            "features": {
                "keywords": [
                    "药明康德",
                    "Summer Bloom",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德(603259.SH)：Summer Bloom完成减持1498.918万股 减持股份",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-11-15",
            "original_text": "药明康德：股东累计减持0.51%股份，减持计划届满 拟减持股份",
            "features": {
                "keywords": [
                    "药明康德",
                    "股东",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德：股东累计减持0.51%股份，减持计划届满 拟减持股份",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-11-15",
            "original_text": "北向资金再度加仓超36亿，东方财富本周净买入近28亿",
            "features": {
                "keywords": [
                    "北向资金",
                    "加仓",
                    "东方财富"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北向资金再度加仓超36亿，东方财富本周净买入近28亿",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-11-15",
            "original_text": "医药板块2021Q3分析暨11月月报：高基数下增速放缓 板块基本面依旧强劲 把握配置窗口期",
            "features": {
                "keywords": [
                    "医药板块",
                    "增速放缓",
                    "基本面强劲",
                    "配置窗口期"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药板块2021Q3分析暨11月月报：高基数下增速放缓 板块基本面依旧强劲 把握配置窗口期",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2023-11-15",
            "original_text": "【最全】2022年中国医药研发外包(CRO)行业上市公司全方位对比(附业务布局汇总、业绩对比、业务规划等)",
            "features": {
                "keywords": [
                    "医药研发外包",
                    "CRO",
                    "上市公司",
                    "业务布局",
                    "业绩对比"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【最全】2022年中国医药研发外包(CRO)行业上市公司全方位对比(附业务布局汇总、业绩对比、业务规划等)",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 10,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        }
    ]
]